AI assistant
OSTEOPORE LIMITED — Capital/Financing Update 2019
Sep 18, 2019
65512_rns_2019-09-18_a69978c0-0432-4470-a7e8-b92cd2ba5166.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
\
19 September 2019
COMPLETION OF ACQUISITION OF OSTEOPORE INTERNATIONAL PTE LTD
Osteopore Limited (ACN 630 538 957) ( Company ) provides the following confirmation to satisfy the conditions for admission of the Company’s securities to quotation on ASX.
The Company confirms that all conditions precedent to the acquisition of 100% of the issued capital of Osteopore International Pte Ltd (UEN No. 200311327H)) ( Acquisition ) have been satisfied (not waived) and the Company has completed the Acquisition.
In accordance with the Implementation Agreement and Short Form Share Sale Agreements, the Company has now issued 71,027,008 Shares to the Osteopore International Pte Ltd shareholders (or their nominees).
In accordance with the Replacement Prospectus, the Company has now issued 2,500,000 Options exercisable at $0.25 expiring on 30 June 2022 at an issue price of $0.0001 to Alto Capital (or its nominees) under the Lead Manager Offer.